The Food and Drug Administration issued a notice on Wednesday advising consumers not to inhale nitrous oxide products sold in ...

The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

Liquidia shares climbed 7.5% after disclosing that it is scheduled to make its first commercial shipment of Yutrepia inhalation powder, days after Food and Drug Administration approval. Shares were ...

The FDA has approved a novel inhalation powder for pulmonary arterial hypertension and interstitial lung disease-associated ...

Liquidia Corporation (NASDAQ:LQDA) announced today that the U.S. Food and Drug Administration (FDA) has approved YUTREPIA ...

The FDA has approved Yutrepia, an inhaled treprostinil formulation, for the treatment of PAH and PH-ILD, two forms of ...

Report Ocean has published a new report on the Saudi Arabia Pharmaceutical Drug Delivery Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities.

This decision came after the full FDA approval of YUTREPIA inhalation powder for adults with pulmonary arterial hypertension ...

"Intentional misuse or inhalation of contents can lead to ... for 65+, others with conditions May 31 (UPI) -- The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days ...

MORRISVILLE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary ...

The Food and Drug Administration just crashed the poppers ... related to the accidental ingestion or purposeful inhalation of ...

The U.S. Food and Drug Administration has reportedly targeted ... and brain death after ingestion or inhalation of nitrite ‘poppers.’” According to Adam Zmith, the author of “Deep Sniff ...